alpha-Synuclein is a small presynaptic
protein implicated in the pathogenesis of
Parkinson disease. Nevertheless, its physiological roles and mechanisms remain incompletely understood.
alpha-Synuclein is not only expressed in neurons but also in the vascular endothelium, which contains intracellular granules called Weibel-Palade bodies (WPBs) that contain a number of
chemokines, adhesive molecules, and inflammatory
cytokines. This study explored whether the exocytosis of WPB is regulated by
alpha-synuclein.
Phorbol 12-myristate 13-acetate-,
thrombin-, or
forskolin-induced
von Willebrand factor release or translocation of
P-selectin from endothelial cells were inhibited by alpha- and
beta-synuclein but not
gamma-synuclein. Three point mutants (A30P, A53T, and E46K) found in familial
Parkinson disease also inhibited WPB exocytosis similar to that of wild-type
alpha-synuclein. Furthermore, the negative regulation of WPB exocytosis required the N terminus or the nonamyloid beta-component of
Alzheimer disease amyloid region of
alpha-synuclein, but not the C-terminal acidic tail, and
alpha-synuclein affected WPB exocytosis through interference with RalA activation by enhancing the interaction of
RalGDS-
beta-arrestin complexes. Immuno-EM analysis revealed that
alpha-synuclein was localized close to WPBs. These findings imply that
alpha-synuclein plays as a negative regulator in WPB exocytosis in endothelial cells.